Dr. Lal Pathlabs Ltd. Investor Presentation

Dr. Lal Pathlabs Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

announcement
Conference/Earnings Calls Alerts
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please find attached a copy of Company''s Q3 & 9M FY21 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2020, approved by the Board of Directors in their meeting held on January 29, 2021. We request you to please take the same on record.
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Please find attached a copy of Company''s Q2 & H1 FY21 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2020, approved by the Board of Directors in their meeting held on November 6, 2020. We request you to please take the same on record.
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Dear Sir/Madam, Please find attached a copy of Company''s Q1 FY21 Earnings Presentation, which the Company proposes to share with Analysts / Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2020, approved by the Board of Directors in their meeting held on July 31, 2020. We request you to please take the same on record.

No results found